Clinical trials
Completed Infections trials in Turkey (Türkiye)
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
33 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 2 |
| 2008 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 4 |
| 2023 | 3 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 33 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| European Organisation for Research and Treatment of Cancer - EORTC | 3 |
| Sisli Hamidiye Etfal Training and Research Hospital | 3 |
| Ataturk University | 2 |
| European Society for Blood and Marrow Transplantation | 2 |
| Kanuni Sultan Suleyman Training and Research Hospital | 2 |
| Ankara University | 1 |
| Aridis Pharmaceuticals, Inc. | 1 |
| Ayşenur Çalış Özbayram | 1 |
| Biruni University | 1 |
| Bulent Ecevit University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Infections | 33 |
| Blast Crisis | 3 |
| Burkitt Lymphoma | 3 |
| Fever | 3 |
| Hodgkin Disease | 3 |
| Leukemia, Hairy Cell | 3 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 3 |
| Leukemia, Myeloid, Accelerated Phase | 3 |
| Leukemia, Myeloid, Acute | 3 |
| Leukemia, Myeloid, Chronic-Phase | 3 |
Trials
Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.